ClinicalTrials.gg
Sign In

pediatric multisystem inflammatory disease, COVID-19 related clinical trials

The registry lists 29 studies for pediatric multisystem inflammatory disease, COVID-19 related across more than 10 countries. 8 are recruiting or about to start. 14 of them are mainly about pediatric multisystem inflammatory disease, COVID-19 related (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-21.

Get an email when these change. Save the pediatric multisystem inflammatory disease, COVID-19 related studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
9
Recruiting
7
Status unknown
7
Withdrawn
2
No longer available
1
Not yet recruiting
1

Phase

Phase 3
2
Phase 1
1
Phase 2
1

Where

United States
7
Poland
3
Denmark
2
Canada
2
United Kingdom
2
Taiwan
2

Who runs them

Medical University of Warsaw (3) · National Taiwan University Hospital (2) · Duke University (2) · Rigshospitalet, Denmark (2) · Kristina Lah Tomulić (1) · Carelon Research (1) · Anglia Ruskin University (1) · Rambam Health Care Campus (1)

What is being tested here

Drugs under test in pediatric multisystem inflammatory disease, COVID-19 related studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Methylprednisolone Hemisuccinate011
Methylprednisolone011
Immunoglobulins, Intravenous011
Immunoglobulin G011
Sulfur Hexafluoride011
Larazotide acetate001
Larazotide001

Coming up

0phase 3 studies under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 7 pediatric multisystem inflammatory disease, COVID-19 related studies recruiting now, 1 (14%) set no upper age limit and 6 (86%) stop at 75 or younger. 7 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (57%) take healthy volunteers.

Recruiting studies that take each age, of 7
AgeWomenMen
107 (100%)7 (100%)
186 (86%)6 (86%)
302 (29%)2 (29%)
402 (29%)2 (29%)
502 (29%)2 (29%)
652 (29%)2 (29%)
751 (14%)1 (14%)
851 (14%)1 (14%)

Across all 29 studies, recruiting or not: 93% stop at 75 or younger and 93% at 65; 97% take children; 0% are for women only and 0% for men only; 31% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 15, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 29 of 29. search them.